Answers are grounded in this paper and cite their sources.
The system for classification of laryngeal cancer was revised following a field study of 19 participating cancer clinics and hospitals in the United States and the T.N.M. Committee of the U.I.C.C. Study of records of 1,645 larynx cancer patients demonstrated that the best survival was experienced by patients with in-situ carcinoma (Tis), 97%. When the tumor was limited to the region of origin (T1), survival was 94% for glottic cancers and 91% for supraglottic cases. As the tumor spread to other regions of the larynx but still confined to the larynx without fixation (T2), survival was 85%–82%; when the larynx was fixed, and tumor still confined to the larynx (T3), survival was 65%–74%, and as the tumor spread outside the larynx (T4) survival dropped to 40%–55%. When cervical lymph node metastases were not fixed, survival was ±50% (hemolateral, bilateral, or contralateral non-fixed metastases). When the regional metastases were fixed, survival dropped to 21%. There were no survivors when the metastases were bilateral and fixed. Grouping the 4 “T”, 4 “N”, and 2 “M” categories into four stages, survival progressively decreased from 94% for Stage I, 85% for Stage II, 59% for Stage III, and 9% for Stage IV for the glottic cases. Similar survival for the supraglottic group was 91%, 82%, 49%, and 9%.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: